Skip to main content
PMN logo

ProMIS Neurosciences, Inc.

PMNNASDAQHealthcareBiotechnology

$8.06Today:- (-)1Y −16.27%

As of Oct 26, 2026 close

Market cap
$73.69M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.27$27.40
Volume (live)
-
Avg. volume (3M)
30.38K

ProMIS Neurosciences (PMN) Income Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), ProMIS Neurosciences posted a net loss of CAD 39.72M, compared with net income of CAD 2.78M a year earlier.

ProMIS Neurosciences Income Statement Analysis

Values in billions CAD

Scroll to see more
ProMIS Neurosciences, Inc. income statement - Annual data in billions CAD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022FY 2021FY 2020FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue0.000.00-0.000.00-0.000.000.00--
Cost of Revenue0.000.000.010.010.000.010.000.000.000.000.00
Gross Profit0.000.00-0.01-0.010.000.000.000.000.00--
Operating Expenses
Research & Development0.030.010.010.010.020.000.00-0.000.010.00
Selling, General & Administrative0.010.010.010.010.010.000.000.000.000.000.00
Operating Expenses0.040.020.020.010.020.010.000.000.010.010.00
Operating Income-0.04-0.02-0.02-0.01-0.02-0.01-0.010.00-0.01--
Other Income/Expense
Interest Income0.000.00-0.000.000.000.000.000.000.000.00
Interest Expense0.000.000.000.000.000.000.00-0.000.00-
Other Income/Expense0.000.020.020.000.010.000.00-0.000.00-
Income
Income Before Tax-0.040.000.00-0.01-0.02-0.01-0.010.00-0.01--
Income Tax Expense0.000.00-0.000.000.000.00-0.000.00-
Net Income-0.040.000.00-0.01-0.02-0.01-0.010.00-0.01--
Net Income - Continuous Operations-0.040.000.00-0.01-0.02-0.01-0.01--0.01--
Net Income - Discontinued Operations-----------
EBITDA-0.040.000.00-0.01-0.02-0.01-0.010.00-0.01--
EBIT-0.04-0.00-0.01-0.02-0.01-0.00---
Depreciation & Amortization0.000.000.000.000.000.000.000.000.00--
Earnings Per Share
Basic EPS-23.003.003.00-27.00-42.00-42.00-23.00-23.00-33.00-47.00-35.00
Diluted EPS-23.003.003.00-27.00-42.00-42.00-23.00-23.00-33.00-47.00-35.00
Basic Shares Outstanding1.760.000.000.000.000.000.000.000.000.000.00
Diluted Shares Outstanding1.760.000.000.000.000.000.000.000.000.000.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ProMIS Neurosciences Financial Statements

Is ProMIS Neurosciences profitable?

No. ProMIS Neurosciences reported a net loss of CAD 39.72M in fiscal 2025. In fiscal 2024 it earned CAD 2.78M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition